AMRN | Amarin Corporation plc Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.5760 - 0.6039
52 Week Range	0.4300 - 1.3600
Beta	2.23
Implied Volatility	251.44%
IV Rank	40.42%
Day's Volume	368,301
Average Volume	1,448,535
Shares Outstanding	411,261,678
Market Cap	242,274,255
Sector	Healthcare
Industry	Biotechnology
IPO Date	1993-04-01

Valuation
Profitability
Growth
Health
P/E Ratio	-5.89
Forward P/E Ratio	N/A
EPS	-0.10
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	275
Country	Ireland
Website	AMRN

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

AMRN's peers: SCLXW, BIIB, GILD, AZN, SNY, NVS, GSK, MRK, BMY, AMGN, ABBV, JNJ

*Chart delayed

Analyzing fundamentals for AMRN we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see AMRN Fundamentals page.

Watching at AMRN technicals we can see that long-term trend is bearish, while middle-term trend is bullish, as well as bullish short-term trend. More technicals details can be found on AMRN Technicals page.